The science behind preventing pregnancy and sexually transmitted diseases is pretty much the same, but it’s a little trickier to apply to people.
In the last 50 years, more than 10 million women have given birth to babies born with a genetic mutation that makes them immune to some or all of the major types of STDs.
But this is a big change, and many experts are still struggling to understand how to harness the newfound protection for pregnant women and their babies.
One of the biggest challenges is that it’s not entirely clear what exactly a vaccine does.
Most people think it prevents infection by itself.
In fact, some researchers have found that the antibodies that can prevent the virus from developing inside the uterus are also found in the bloodstream.
But researchers have been able to find only one vaccine that is effective against both STDs and pregnancy.
It’s called a recombinant vaccine.
Researchers have developed a vaccine that they say can help women with the disease and their unborn babies.
But there are many hurdles to getting it off the ground, including funding, regulatory approval, and finding a vaccine candidate.
A new study, published in the Journal of Clinical Investigation, has some promising results.
It suggests that the vaccine can prevent both pregnancy and birth defects in mice, which may help the vaccine be more widely adopted in the coming years.
Researchers from the University of Oxford and the University College London have developed recombinant vaccines that target the gene responsible for the T-cell immune response to certain types of foreign pathogens.
The vaccine targets a particular protein in the immune system called IL-1β, which is also responsible for some of the immunological changes that happen during pregnancy.
The scientists used a modified version of the T cell gene to create the vaccine.
In some people, this gene is mutated and the T cells are unable to recognize and fight off foreign invaders.
But in other people, the T and B cells, which are the cells that help the immune systems fight off infection, are also mutated.
This means that when the T is knocked out, the B cells in the body are not able to fight off the invaders.
Researchers then injected the modified T-cells into pregnant mice and found that they successfully prevented both pregnancy AND birth defects.
In other words, the vaccine prevented both STIs and birth abnormalities.
The next step for the researchers is to figure out how to make a vaccine against the T virus, which can cause a range of serious birth defects, including brain damage, deafness, and brain tumors.
The researchers are now testing a small amount of the vaccine in pregnant women in the United Kingdom.
The goal is to have a vaccine for pregnant mice available for testing by the end of the year.
The findings could have wide-ranging implications for the vaccine field.
“Our next step is to try to get a vaccine to a much wider population and then start to test it in other populations,” said study leader, Prof. James Gavitt, who studies vaccines at the University’s School of Biological Sciences.
“We’re not going to have this vaccine for people in other parts of the world, because there are lots of barriers that prevent the development of that vaccine.”